JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 217K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blystone, S. D.
Right arrow Articles by Brown, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blystone, S. D.
Right arrow Articles by Brown, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1999//889 $5.00
The Journal of Cell Biology, Volume 145, Number 4, , 1999 889-897


Regular Articles

A Molecular Mechanism of Integrin Crosstalk: {alpha}vβ3 Suppression of Calcium/Calmodulin-dependent Protein Kinase II Regulates {alpha}5β1 Function



Scott D. Blystone*, Suzanne E. Slater{ddagger}, Matthew P. Williams*, Michael T. Crow§, and Eric J. Brown||

* Department of Anatomy and Cell Biology, State University of New York, Health Science Center at Syracuse, Syracuse, New York 13210; {ddagger} Department of Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, 63110; § Vascular Biology Unit, Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224; and || Program in Microbial Pathogenesis and Host Defense, University of California, San Francisco, California 94143

Many cells express more than one integrin receptor for extracellular matrix, and in vivo these receptors may be simultaneously engaged. Ligation of one integrin may influence the behavior of others on the cell, a phenomenon we have called integrin crosstalk. Ligation of the integrin {alpha}vβ3 inhibits both phagocytosis and migration mediated by {alpha}5β1 on the same cell, and the β3 cytoplasmic tail is necessary and sufficient for this regulation of {alpha}5β1. Ligation of {alpha}5β1 activates the calcium- and calmodulin-dependent protein kinase II (CamKII). This activation is required for {alpha}5β1-mediated phagocytosis and migration. Simultaneous ligation of {alpha}vβ3 or expression of a chimeric molecule with a free β3 cytoplasmic tail prevents {alpha}5β1-mediated activation of CamKII. Expression of a constitutively active CamKII restores {alpha}5β1 functions blocked by {alpha}vβ3-initiated integrin crosstalk. Thus, {alpha}vβ3 inhibition of {alpha}5β1 activation of CamKII is required for its role in integrin crosstalk. Structure-function analysis of the β3 cytoplasmic tail demonstrates a requirement for Ser752 in β3-mediated suppression of CamKII activation, while crosstalk is independent of Tyr747 and Tyr759, implicating Ser752, but not β3 tyrosine phosphorylation in initiation of the {alpha}vβ3 signal for integrin crosstalk.

Key Words: integrin • vitronectin • kinase • cross- talk • signaling



Abbreviations used in this paper: CamKII, calcium/calmodulin-dependent protein kinase II; FN, fibronectin; IMDM, Iscove's Modified Eagle's Medium; LIBS, ligand-induced binding site; MLCK, myosin light chain kinase; VN, vitronectin.

Address correspondence to Dr. Scott D. Blystone, Anatomy and Cell Biology, SUNY Health Science Center at Syracuse, 750 East Adams Street, Syracuse, NY 13210. Tel.: (315) 464-8512. Fax: (315) 464-8535. E-mail: blystons{at}vax.cs.hscsyr.edu

DYNAMIC interaction of cells with the complex protein mixtures found in the extracellular matrix occurs during many biologic and pathologic processes including development, wound healing, hemostasis, metastasis, inflammation, and thrombosis (13, 18). Most cells express multiple integrin receptors capable of interaction with the numerous ligands found in complex tissues. The simultaneous ligation of multiple integrins mandates coordination of the resulting signals. The coordination of integrin signaling into a hierarchy with a net effect on cell behavior has been called integrin crosstalk (2, 3, 17).

Numerous examples of integrin crosstalk have been reported. The common theme of these reports lies in the regulation of the function of one integrin (the target) as a result of coligation of a second integrin (the transducer) on the same cell. Examples of integrin crosstalk have been demonstrated in numerous primary cell types and cell lines including macrophages (2), T cells (17, 23), smooth muscle cells (1), neutrophils (10), monocytes (15), umbilical vein endothelial cells (20), malignant astrocytomas (16), CHO cells (7, 9), K562 cells (2, 3), and embryonic kidney 293 cells (20). Crosstalk may be initiated by transducing integrins belonging to the β1 (11, 15, 16, 22), β2 (17, 23), or β3 (13, 7, 9, 10, 20) family with targets in any of these families as well. Integrin functions affected by crosstalk include phagocytosis (2, 3, 10), soluble ligand binding (7, 15), adhesion (9, 17, 23), migration (1, 17, 20), gene expression (11), and receptor-mediated endocytosis (16).

It is important to note that all reported cases of integrin crosstalk are unidirectional, that is, ligation of the target integrin does not affect the transducer integrin. In many cases, the transducing integrin is much less highly expressed than the target integrin (2, 3). This suggests a hypothesis that the receptor pairs involved in crosstalk are not simply competing for interaction with a signaling molecule, but rather that ligation of the transducing integrin initiates a unidirectional signaling cascade which affects the function of the target integrin. The molecular mechanisms of integrin crosstalk remain undetermined. With a single exception (20), crosstalk signals from the transducing integrin require the cytoplasmic tail of the β-subunit, and where it has been examined, the β-subunit cytoplasmic tail has been sufficient for initiation of signaling (3).

We have previously described integrin crosstalk between {alpha}vβ3 and {alpha}5β1 in macrophages and in a K562 cell transfection model of macrophage integrins (2, 3). We have shown that ligation of {alpha}vβ3 inhibits {alpha}5β1-mediated phagocytosis, which requires the high affinity state of the integrin, without affecting {alpha}5β1-mediated adhesion, which is independent of the high affinity state of the integrin. The cytoplasmic tail of β3 is necessary and sufficient for this crosstalk. {alpha}vβ3-mediated inhibition of {alpha}5β1 phagocytosis occurs at a step subsequent to {alpha}5β1 binding of ligand and is reversed by H7, a pharmacologic inhibitor of serine/ threonine kinases.

In this report, we define a molecular mechanism required for {alpha}vβ3-to-{alpha}5β1 crosstalk. Ligation of {alpha}5β1 enhances the activity of the calcium/calmodulin-dependent protein kinase II (CamKII)1. This increase in CamKII activity is required for {alpha}5β1-dependent migration as well as {alpha}5β1-dependent phagocytosis. Simultaneous ligation of {alpha}vβ3 inhibits {alpha}5β1 activation of CamKII activity, thus blocking {alpha}5β1 migration and phagocytosis. Mutational analysis of the β3 cytoplasmic tail demonstrates that Ser752 is required for both {alpha}vβ3-initiated inhibitory crosstalk to {alpha}5β1 and {alpha}vβ3 suppression of CamKII activity, while tyrosine phosphorylation of the β3 cytoplasmic tail has no effect on this activity. These results describe a potential molecular pathway for integrin crosstalk that involves integrin regulation of CamKII activity.


   Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Cells and β3 cDNA Mutation
Human peripheral blood monocyte-derived macrophages were prepared as previously described (2). The human erythroleukemic cell line K562 transfected with cDNA encoding {alpha}vβ3 (K{alpha}vβ3), {alpha}vβ3 in which the tyrosine residue at position 747 or 759 was mutated to phenylalanine (K{alpha}vβ3Y747F and K{alpha}vβ3Y759F, respectively) and Tacβ3 (chimera of the extracellular and transmembrane domain of the IL2 receptor {alpha}-chain [Tac subunit] and the cytoplasmic tail of β3, KTacβ3) were derived and maintained as described (2, 3). In addition K562 cells were similarly transfected with cDNA encoding Tacβ3 in which the serine residue at position 752 was replaced with proline (KTacβ3S-P), cysteine (KTacβ3S-C), alanine (KTacβ3S-A), or glutamic acid (KTacβ3S-E). Expression of all Tacβ3S-X chimeras was equivalent to Tacβ3 (3) as determined by flow cytometry as described (2; see Table I). For construction of Tacβ3S-X, the HindIII and XhoI fragment of pTacβ3 encoding the CT of β3 (3) was ligated into HindIII-XhoI–digested pBluescript (Stratagene), creating pBSKSPB3TAIL. This contruct was subjected to PCR using a 5' T7 oligonucleotide (Stratagene) with the 3' oligonucleotide (5'-CCCCCCTCGAGTTAAGTGCCCCGGTACGTGATATTGGTGAAGGT-XXX-CGTGGC-3') where XXX is AGG for S752P, ACA for S752C, GCT for S752A, and TTC for S752E. The resulting products were digested with HindIII-XhoI and ligated into pTacβ3 digested with HindIII-XhoI, creating pTacβ3S-P, pTacβ3S-C, pTacβ3S-A, and pTacβ3S-E, respectively.


View this table:
[in this window]
[in a new window]

 
Table I Integrin Expression in Transfected K562 Cells

 
K562 cells also were transfected with full-length {alpha}vβ3 in which the serine at position 752 of β3 was mutated to alanine as described for the mutation of β3 tyrosine residues (4). In brief, nested PCR was performed on pBLY100 using the overlapping oligonucleotides 5'-GAGGCCACGCCTACCTTCACCAATATCACG-3' and 5'-CTCCGGTGCGGATGGAAGTGGTTATAGTGC-3' encoding the S-A mutation with oligonucleotides in the mutation cassette (4). After the nested PCR reaction, the wild-type β3 CT was replaced with the S-A mutant CT by NdeI-NheI restriction. Transfection, selection, and fluorescent cell sorting for expression levels of {alpha}vβ3S752A equivalent to wild-type {alpha}vβ3 was as described previously, resulting in K{alpha}vβ3S752A (Table I). Modified cDNAs were verified by dideoxy nucleotide sequencing.

Phagocytosis, Adhesion, and Migration
Phagocytosis assays were performed as described (2) by flow cytometry using either FITC-FN– or FITC-mAb16 (anti-{alpha}5)–coated 3.0-µm beads. Data are presented as a Phagocytic Index, the number of beads internalized per 100 cells.

Chemotaxis assays were performed in modified Boyden chambers (Neuroprobe) using 14.0-µM polycarbonate filters as described (19). Vitronectin (VN), fibronectin (FN), and BSA were added to basal chambers at 5 µg/ml and mAb at 10 µg/ml were added to apical chambers coincident with cells. Cells in Iscove's Modified Eagle's Medium (IMDM) adjusted to 1 mM Ca2+ and 1 mM Mg2+ with 0.5% human serum albumin and 2.0 mM Mn2+Cl were incubated for 4 h at 37°C in a humidified 5% CO2 atmosphere for migration. Migration was quantitated by counting the number of cells per high power field on the underside of the filter after Giemsa staining.

Adhesion assays were performed as described in FN-coated (10 µg/ml) microtiter wells (2). Data are presented as the percent of added cells adherent after 1 h at 37°C.

CamKII Activity Assay
Transfected K562 cells or monocyte-derived macrophages were stimulated as described in the text, washed once by centrifugation in ice-cold IMDM and suspended in ice-cold homgenization buffer containing Hepes (50 mM), EDTA (4 mM), EGTA (2 mM), sucrose (0.25 M), dithiothreitol (1 mM), phenylmethylsulfonyl fluoride (0.2 mM), Na3VO4 (2.0 mM), NaF (5.0 mM), phenyl-arsine-oxide (10.0 mM), and leupeptin (10 µg/ml), pH 7.5. Suspended cells were sonicated on ice and assayed for CamKII activity against the synthetic substrate autocamtide II (KKALRRQETVDAL) (21). An aliquot of cell extracts was used for protein determination by BCA. Parallel aliquots were assayed for CamKII activity in a 25-µl reaction mixture containing Hepes (50 mM), magnesium acetate (10 mM), Na3VO4 (2.0 mM), NaF (5.0 mM), phenyl-arsine-oxide (10.0 mM), CaCl2 (1 mM), calmodulin (0.1 µM; Sigma Chemical Co.), autocamtide II (20 µM), and {gamma}-[32P]ATP (0.1 mM, 3,000 cpm/pmol). The reaction was initiated by ATP addition and terminated by addition of trichloroacetic acid to a final concentration of 10%. The reaction mixture was centrifuged through phosphocellulose separation units (Pierce) and washed as described (26). CamKII activation results from phosphorylation events that result in kinase activity which is no longer dependent upon exogenous calcium or calmodulin. CamKII activity in cellular extracts was measured by quantitating the incorporation of radioactive phosphate into a synthetic CamKII substrate (autocamtide-2) in the presence (calcium/calmodulin-independent + calcium/calmodulin-dependent activity) or absence (calcium/calmodulin-independent activity) of calcium and calmodulin. The activation of CamKII (autonomous activity) is expressed as a direct percentage of the total cellular CamKII activity (1) in which:

Formula

where autonomous activity equals the CamKII activity without calcium or calmodulin and total activity equals CamKII activity with calcium or calmodulin.

CamKII expression levels in transfected cell lines was assessed by immunoprecipitation as previously described, followed by Western blot analysis (1).

Infection of K562 Cells with Adenovirus Encoding Constitutively Active CamKII
K{alpha}vβ3, KTacβ3, and KTacβ5 were infected with a replication defective adenovirus in which the E1 region was replaced with the CMV early promoter and the cDNA for a constitutively active CamKII (AdCMV.CKIID3) or β-galactosidase (AdCMV.gal) and viral stocks propagated and titered as described (1). Transfected K562 cells at 5 x 106/ml in IMDM were infected with recombinant adenovirus at a multiplicity of infection of 100 for 1 h followed by the addition of normal growth medium to dilute cells to a concentration of 0.5 x 106/ml. After 4–6 h, cells were harvested for analysis of CamKII activity or functional assay as described in Results. Viability of all infected cell types exceeded 85% at the initiation, and 70% at the conclusion of experimental time courses.

Proteins and Antibodies
FN was purified by gelatin affinity and VN by heparin affinity as previously described (2, 3). Monoclonal antibodies 7G2 (anti–human β3), W6/ 32 (anti–human HLA), IC12 (anti–human {alpha}v), AP3 (anti–human β3), P1F6 (anti–human β5), 4E3 (anti-IL2R{alpha}, gp55, TAC), and mAb16 (anti– human {alpha}5) have been previously described and were used in excess at 5.0 µg/ml unless otherwise indicated (2, 3).

Reagents
The kinase inhibitors H7 (50 nM), KN62 (2.5 µM), KN04 (5.0 µM), KT5926 (20 nM), and ML-9 (2 µM) were included in some assays where indicated and all were from LC Laboratories (Woburn, MA). All other reagents were from Sigma Chemical Co. unless otherwise indicated.

Data Presentation
Data are presented as the mean ± SEM from at least three replicates for all studies. Significance was determined by analysis of variance followed by Duncan's comparison testing. A minimum confidence interval of 95% was employed for all studies.


   Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
{alpha}vβ3 Crosstalk Regulates {alpha}5β1-mediated Migration
We have previously described a phenomenon, termed integrin crosstalk, in which ligation of {alpha}vβ3 prevents {alpha}5β1-mediated phagocytosis in macrophages and in K562 cells expressing transfected {alpha}vβ3. To determine if integrin crosstalk regulated {alpha}5β1 functions other than phagocytosis, we evaluated the effects of {alpha}vβ3 ligation on the migration of K562 cells on the {alpha}5β1 ligand FN. K562 cells did not migrate specifically to FN in IMDM containing 1 mM Ca2+ and 1 mM Mg2+. However, addition of 2 mM Mn2+ or the {alpha}5β1 conformation-stabilizing mAbs 8A2 or A1A5 at 5.0 µg/ml greatly enhanced the FN-specific migration of these cells, consistent with a requirement for high affinity {alpha}5β1 in migration (data not shown). As shown in Fig. 1 A, the migration of untransfected K562 to FN in the presence of 2 mM Mn2+ was enhanced sixfold over migration to the nonspecific protein casein; this migration was completely inhibited by mAb to {alpha}5β1 (data not shown). We also examined {alpha}vβ3-mediated migration in K562 expressing this transfected integrin in addition to the endogenous {alpha}5β1. K{alpha}vβ3 migrated in response to VN (Fig. 1 A); migration response to VN was inhibited by mAb to {alpha}v or β3 (data not shown). However, migration of K{alpha}vβ3 to FN was severely impaired compared with untransfected or mock transfected K562 (Fig. 1 A). Migration of K{alpha}vβ3 to FN was restored by the addition of the ser/thr kinase inhibitor H7 (50 nM), while addition of H7 had no effect on K{alpha}vβ3 migration to VN (data not shown). Restored migration of K{alpha}vβ3 to FN in the presence of H7 was completely inhibited by mAb to β1 (data not shown). These results completely parallel the previously described {alpha}vβ3-mediated crosstalk which inhibits {alpha}5β1-mediated phagocytosis (3) and support the hypothesis that the coligation of {alpha}vβ3 by FN regulates {alpha}5β1-mediated K562 cell migration to FN because this function, like phagocytosis, requires a high affinity form of {alpha}5β1.


Figure 1
Figure 1
View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 {alpha}vβ3 crosstalk regulates {alpha}5β1-mediated migration. Untransfected K562 cells, K{alpha}vβ3, KTacβ3, and KTacβ5 were permitted to migrate to vitronectin (VN), fibronectin (Fn) or casein through 14.0-µM pores in a modified Boyden chamber apparatus as described in Materials and Methods (A). For structure-function analysis of integrin crosstalk, untransfected K562 cells and K562 cells expressing transfected wild-type {alpha}vβ3 (K{alpha}vβ3) or {alpha}vβ3 bearing single amino acid mutations Tyr747-Phe (K{alpha}vβ3Y747F), Tyr759-Phe (K{alpha}vβ3Y759F) or Ser752-Ala (K{alpha}vβ3S752A) were assayed for migration to Fn, VN, or casein as described in Materials and Methods (B). Migration was quantitated manually by counting cells adherent to the basal side of the filter and reported as the number of cells per well. Shown are mean ± SEM of four determinations with no fewer than eight replicates.

 
To demonstrate definitively that {alpha}vβ3 regulation of {alpha}5β1-mediated migration was another example of integrin crosstalk, we examined migration to FN in KTacβ3 and KTacβ5, K562 cells expressing chimeric molecules comprised of the extracellular domain of the IL2 receptor and the cytoplasmic tail domain of the β3 or β5 integrin, respectively. Expression of Tacβ3, but not Tacβ5, leads to constitutive inhibition of {alpha}5β1-mediated phagocytosis in K562 cells (3; see Fig. 7 B). Expression of Tacβ3, but not Tacβ5 (Fig. 1 A) or Tac lacking a cytoplasmic tail (KTacNT, Fig. 2 A), completely inhibited {alpha}5β1-mediated migration to FN. The constitutive inhibition of migration to FN in KTacβ3 was reversed by the addition of 50 nM H7 (Fig. 2 A). These studies demonstrate that {alpha}5β1-mediated migration and {alpha}5β1-mediated phagocytosis are similarly regulated by {alpha}vβ3 or the isolated β3 CT and that this regulation is dependent upon a ser/thr kinase regulated by H7. These data suggest that both {alpha}5β1-mediated migration and {alpha}5β1-mediated phagocytosis are regulated by {alpha}vβ3-initiated crosstalk.


Figure 2
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Role of β3 Ser752 in {alpha}vβ3 crosstalk. K562 cells transfected with vector alone (Rc/RSV) or a chimeric molecule composed of the extracellular and transmembrane domains of the IL2 receptor (Tac) and the cytoplasmic tail of integrin subunits; no tail (TacNT), β3 (Tacβ3), β5 (Tacβ5), or β3 in which Ser752 had been mutated to Pro (Tacβ3S-P), Cys (Tacβ3S-C), Ala (Tacβ3S-A), or Glu (Tacβ3S-E) were evaluated for their ability to migrate to FN (A), phagocytose FN opsonized beads (B), and adhere to FN-coated tissue culture plastic (C) as described in Materials and Methods. Parallel samples were treated with 50 nM H7 as indicated. Shown are mean ± SEM of no fewer than three determinations performed in triplicate.

 
β3 Ser752 Is Required for β3 Crosstalk
We have previously demonstrated that expression of the isolated β3 cytoplasmic tail is sufficient for initiation of {alpha}vβ3 crosstalk (Fig. 1 A and reference 12). To further delineate the required sequence elements of this unique regulatory pathway, we introduced point mutations in the β3 cytoplasmic tail and analyzed their effects upon {alpha}vβ3-initiated crosstalk to {alpha}5β1-mediated migration.

In a spontaneously occurring Glanzmann's Thrombasthenia mutation, the serine residue at position 752 of the β3 CT is mutated to proline (6). This mutation results in loss of platelet β3 function and a severe bleeding disorder. In vitro study has shown that Ser752 of the β3 CT is required for the conformational change associated with elevated affinity of β3 for ligand (8). To test whether Ser752 also is required for integrin crosstalk, we expressed an {alpha}vβ3 receptor in K562 cells in which Ser752 of β3 was mutated to Ala (Fig. 1 B). While the ligation of wild-type {alpha}vβ3 blocked {alpha}5β1-mediated migration on FN (Fig. 1 B), the S752A mutant migrated as well as the untransfected cells. In addition, the S752A mutant migrated as well as wild-type {alpha}vβ3 on VN (Fig. 1 B), consistent with reports that this mutation does not affect ligand binding by β3 integrins (8). This demonstrates that failure of the S752A mutant to initiate crosstalk did not result from an inability to recognize ligand.

Recently, a tyrosine in the β3 cytoplasmic tail, Tyr747, has been implicated in activation-dependent {alpha}vβ3 adhesion to VN (4). In contrast to the S752A mutation, Y747F had no effect on {alpha}vβ3-initiated integrin crosstalk (Fig. 1 B). Consistent with the previous report of a requirement for this tyrosine in firm adhesion, the Y747F mutation did abolish migration of K{alpha}vβ3Y747F to VN (Fig. 1 B). Mutation of Tyr759 to Phe (Y759F) did not affect either crosstalk or the migration function of {alpha}vβ3. These data demonstrate that the crosstalk signaling and adhesive functions of {alpha}vβ3 have distinct and independent sequence requirements in the β3 cytoplasmic tail.

To evaluate further the requirement for β3 S752 in integrin crosstalk, additional mutations at that position were made in the consititutively inhibitory Tacβ3 construct. Mutation of Ser752 to Glu, Pro, or Cys as well as Ala abolished the inhibitory activity of Tacβ3 on {alpha}5β1-dependent migration (Fig. 2 A) and {alpha}5β1-dependent phagocytosis (Fig. 2 B). Like the wild-type β3 cytoplasmic tail, none of the mutants affected K562 binding to FN-coated surfaces, a function that does not require the high affinity state of {alpha}5β1 (Fig. 2 C). The addition of H7 reversed the Tacβ3 inhibition of {alpha}5β1-mediated migration and phagocytosis (Fig. 2, A and B).

{alpha}5β1 and {alpha}vβ3 Differentially Regulate CamKII
{alpha}vβ3 ligation inhibits the {alpha}5β1 high affinity functions of phagocytosis and migration, without effect upon {alpha}5β1-mediated adhesion. Alterations in {alpha}5β1 affinity can be regulated by calcineurin, a calcium/calmodulin-dependent phosphatase and CamKII (calcium/calmodulin-dependent protein kinase II; reference 1). Recently, inhibition of CamKII activity by {alpha}vβ3 ligation in smooth muscle cells was reported (1). Therefore, we evaluated {alpha}vβ3 regulation of CamKII as a potential mediator of {alpha}vβ3-initiated crosstalk.

CamKII activity was measured in human monocyte-derived macrophages in the presence and absence of an {alpha}5β1-specific phagocytosis target (mAb-16–coated latex beads) (3). Ligation of macrophage {alpha}5β1 with mAb-16 beads enhanced CamKII activity twofold, while ligation with a control target (W6/32 beads) had no effect (Fig. 3 A). Both basal and stimulated CamKII activities were decreased by the CamKII inhibitor KN62, but not the structurally related, but non-inhibitory KN04. Ligation of {alpha}vβ3 with soluble mAb 7G2 prevented the rise in CamKII activity induced by mAb-16 beads (Fig. 3 A). No additional decrease in CamKII activity was detected when KN62 and 7G2 were combined. Thus, β3 ligation prevented the {alpha}5β1-induced rise in CamKII activity.


Figure 3
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Regulation of CamKII activity by {alpha}5β1 and {alpha}vβ3. Human monocyte-derived macrophages (A) or K562 cells expressing transfected {alpha}vβ3 (K{alpha}vβ3, B) or integrin β5 (KTacβ5) or β3 (KTacβ3) cytoplasmic tail chimeras (C) were assayed for activity of the calcium- and calmodulin-dependent protein kinase II against a synthetic substrate as described in Materials and Methods. Cells were either left unstimulated (no beads) or presented with control phagocytosis targets (W6/32 beads) or with an {alpha}5β1-specific phagocytosis target (mAb-16 beads) in the presence and absence of KN62 (2.5 µM), KN04 (5.0 µM) or 5.0 µg/ml mAb 7G2 either individually or in combinations as indicated. D shows the inhibition of CamKII activity in K{alpha}vβ3 after {alpha}5β1 ligation with mAb-16 beads by soluble mAb 7G2 (5.0 µg/ml), 7G2 Fab' (3.8 µg/ml), and 2.0 mM GRGDSP peptide and the lack of inhibition by mAb P1F6 or 2 mM GRGESP. Regulated CamKII activity is presented as the percent of total activity as described in Materials and Methods. Shown are mean ± SEM for no fewer than three determinations in each group of all panels.

 
To explore further the hypothesis that CamKII mediates {alpha}vβ3 regulation of {alpha}5β1, we evaluated the regulation of CamKII in K{alpha}vβ3. Binding of mAb-16 beads to K{alpha}vβ3, and to vector-transfected K562 (data not shown), resulted in an increase in CamKII activity (Fig. 3 B) that was not seen when K{alpha}vβ3 were incubated with W6/32 beads that bound to the cells equivalently. As in macrophages, the {alpha}5β1-mediated rise in CamKII activity was prevented by ligation of {alpha}vβ3 with soluble mAb 7G2 (Fig. 3 B) and by 7G2 Fab fragments or Arg-Gly-Asp peptide (Fig. 3 D). As seen in macrophages, inhibition of the {alpha}5β1-induced increase in CamKII activity by {alpha}vβ3 ligation was blocked by KN62, but not KN04.

Previously we have demonstrated that the cytoplasmic tail of β3 is both necessary and sufficient for {alpha}vβ3 inhibitory crosstalk to {alpha}5β1 (reference 3 and Fig. 2, A and B). In the presence of mAb-16 beads, expression of Tacβ3, but not Tacβ5, prevented the {alpha}5β1-mediated rise in CamKII activity (Fig. 3 C). These results indicate that {alpha}5β1 and {alpha}vβ3 differentially regulate CamKII activity in macrophages and K562 cells.

To determine if the failure of the K{alpha}vβ3S752A to initiate crosstalk was related to an inability to regulate CamKII, we evaluated CamKII activity after mAb-16 bead binding in K562 cells transfected with wild-type {alpha}vβ3 and the S752A and Y747F mutants. While ligation of {alpha}vβ3 with the β3-specific mAb 7G2 suppressed mAb-16 bead-induced activation of CamKII, mutation of Ser752 of β3 prevented the suppression of CamKII activity seen upon {alpha}vβ3 ligation (Fig. 4 A). However, mutation of Tyr747 or Tyr759 (data not shown) did not affect {alpha}vβ3 regulation of CamKII. Thus, Ser752 is required for both {alpha}vβ3 inhibitory crosstalk to {alpha}5β1 (Fig. 2) and {alpha}vβ3 regulation of CamKII (Fig. 4).


Figure 4
Figure 4
View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Role of β3 Ser752 in {alpha}vβ3 regulation of CamKII. Untransfected K562 cells or K562 cells expressing transfected wild-type {alpha}vβ3 (K{alpha}vβ3) or {alpha}vβ3 in which Tyr747 was mutated to Phe (K{alpha}vβ3Y747F) or in which Ser752 was mutated to Ala (K{alpha}vβ3S752A) were assayed for CamKII activity (A) as described in Materials and Methods, after {alpha}5β1 ligation with mAb-16 beads in the presence or absence of the {alpha}vβ3 ligand 7G2 (5.0 µg/ml). Shown are mean ± SEM of three determinations with no fewer than three replicates. Also as described in Materials and Methods, total cellular CamKII (see arrow) from transfected K562 cell populations used in this study was recovered by immunoprecipitation and revealed by Western blotting (B). For untransfected K562 cells, cell lysates were cleared by immunoprecipitation with anti-CamKII twice (cleared 2x) or once (cleared 1x), before analysis of the final immunoprecipitation to ensure that recovery of protein was complete. Shown is a representative study.

 
To determine the effect of {alpha}vβ3 and mutant β3 on expression of CamKII, immunoprecipitates of CamKII were analyzed by Western blot with CamKII-specific Ab. As shown in Fig. 4 B, cellular expression of CamKII (see arrow) was unchanged by the expression of {alpha}vβ3 and mutants in transfected K562 cells.

Role of CamKII in {alpha}vβ3 Crosstalk to {alpha}5β1
Suppression of the {alpha}5β1-dependent increase in CamKII activity by {alpha}vβ3 ligation or by Tacβ3 expression suggested that CamKII regulation could have a role in {alpha}vβ3 crosstalk to {alpha}5β1. To determine the role of CamKII in {alpha}vβ3 crosstalk to {alpha}5β1, K{alpha}vβ3 cells were incubated with the {alpha}5β1 phagocytosis target, mAb-16 beads, or control target, P1F6 (anti-{alpha}vβ5) beads. Phagocytosis was measured in the presence and absence of 7G2 to ligate {alpha}vβ3, the CamKII inhibitor KN62, or control KN04. As reported previously, phagocytosis via {alpha}5β1 was inhibited upon {alpha}vβ3 ligation with mAb 7G2 (2, 3). {alpha}5β1 phagocytosis also was inhibited by KN62 (Fig. 5 A), but not KN04. Combining 7G2 and KN62 resulted in no further decrease in {alpha}5β1 phagocytosis. Under all conditions, there was no significant internalization of P1F6 beads.


Figure 5
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Effects of CamKII inhibitors on {alpha}5β1 function and {alpha}vβ3 crosstalk. Phagocytosis of the {alpha}5β1-specific target mAb-16 beads, or control target P1F6-beads was evaluated in K562 expressing {alpha}vβ3 in the presence and absence of {alpha}vβ3 ligation by mAb 7G2 (5.0 µg/ml) and/or the CamKII inhibitor KN62 (2.5 µM) or control KN04 (5.0 µM) (A) as described in Materials and Methods. Shown are mean ± SEM of three determinations with four replicates each. {alpha}5β1-mediated phagocytosis of FN beads was evaluated in untransfected K562 cells in the presence and absence of KN62 (2.5 µM), KN04 (5.0 µM), or the β3-specific mAb 7G2 (5.0 µg/ml) (B) as described in Materials and Methods. Shown are the mean ± SEM of two determinations with three replicates each. In C, the migration of untransfected K562 cells, K{alpha}vβ3, KTacβ3, and KTacβ5 to FN was assessed in the presence and absence of KN62 (2.5 µM) or KN04 (5.0 µM) as described in Materials and Methods. Shown are mean ± SEM of four determinations with at least three replicates each.

 
To determine the dependence of {alpha}5β1 phagocytosis on CamKII activation, we evaluated phagocytosis in untransfected K562 cells which express {alpha}5β1, but not {alpha}vβ3. The absence of {alpha}vβ3 in these cells permitted the use of FN-coated beads as a phagocytosis target for {alpha}5β1 rather than the more selective mAb-16 beads used when {alpha}vβ3 is present. K562 phagocytosis of FN-coated beads via {alpha}5β1 was inhibited by the CamKII inhibitor KN62 (Fig. 5 B), but not the control KN04. Thus, enhanced CamKII activity, initiated by {alpha}5β1 binding of mAb-16 beads, appears to be required for {alpha}5β1 phagocytosis.

These data support the hypothesis that ligation of {alpha}5β1 stimulates CamKII activity and that {alpha}vβ3-mediated suppression of this activity is at least in part responsible for its inhibition of {alpha}5β1-mediated phagocytosis. To demonstrate that a similar mechanism was responsible for the inhibitory β3 crosstalk to {alpha}5β1 during migration, we evaluated the effects of the CamKII inhibitor KN62 on K562 cell migration in response to FN. KN62, but not the inactive analogue KN04, inhibited the FN-induced migration of mock transfected K562 cells and KTacβ5 (Fig. 5 C). The presence of KN62 did not further attenuate the minimal migration of K{alpha}vβ3 or KTacβ3 cells.

Constitutively Active CamKII Overcomes {alpha}vβ3-Inhibitory Integrin Crosstalk
To test the hypothesis that {alpha}vβ3 crosstalk to {alpha}5β1 was a result of CamKII downregulation by β3, K562 cells were infected with an adenovirus-directing expression of a constitutively active form of CamKII (1). Expression of this construct in untransfected K562 cells resulted in an eightfold increase in CamKII activity over a control viral construct encoding β-galactosidase (Fig. 6 A).


Figure 6
Figure 6
View larger version (33K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Constitutively active CamKII reverses {alpha}vβ3 inhibitory crosstalk. Untransfected K562 cells (A), or KTacβ3 and KTacβ5 (B) were infected with an adenovirus encoding either β-galactosidase (AdCMV.gal) or a constitutively active form of CamKII (AdCMV.CKIID3). CamKII activity against a synthetic substrate was assayed in the presence and absence of calmodulin and the CamKII inhibitor KN62 (2.5 µM) as described in Materials and Methods and reported as the CamKII activity per mg of total cellular protein (A). Migration of KTacβ3 and KTacβ5 expressing either β-galactosidase or constitutively active CamKII to FN was assessed as described in Materials and Methods (B). Shown are mean ± SEM of three determinations performed in triplicate.

 
Next, KTacβ3 and KTacβ5 infected with virus encoding either β-galactosidase or constitutively active CamKII were assayed for their ability to migrate in response to FN. Expression of the active kinase specifically overcame the constitutive inhibition of {alpha}5β1-mediated migration in KTacβ3, without any effect on migration in KTacβ5 (Fig. 6 B). Thus, expression of active CamKII overcame {alpha}vβ3-mediated suppression of {alpha}5β1 high affinity functions. Unfortunately, safety concerns precluded testing the effect of the constitutively active CamKII in the phagocytosis assay.


   Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Integrin crosstalk is an important mechanism for coordinating signals from multiple simultaneously ligated integrins on a single cell for a functional response to extracellular matrix. Although sometimes called "transdominant inhibition," crosstalk may induce, as well as suppress functions of the target integrin, so we believe the more general term, preferable (9). Although the number of examples of integrin crosstalk has rapidly expanded in the past few years, little is known concerning the molecular mechanisms by which one integrin affects the function of another. K562 cells have proved a valuable model for examination of integrin crosstalk because these cells express a single integrin, {alpha}5β1, permitting a wide variety of genetic experiments exploring the basis of integrin crosstalk. In this system, we have previously shown that ligation of transfected {alpha}vβ3 inhibits the high affinity phagocytic function of {alpha}5β1 without effect upon low affinity {alpha}5β1-mediated adhesion and that the β3 cytoplasmic tail is both necessary and sufficient for this effect. We now have used this model to explore the biochemical mechanisms involved in crosstalk. Based on a previous report, we examined a potential role for CamKII in {alpha}vβ3-mediated suppression of the high affinity functions of {alpha}5β1, and performed structure-function analysis of the β3 cytoplasmic tail to further delineate the required structures for this unique signaling event.

In this study, we show that either {alpha}vβ3 ligation or expression of the isolated β3 cytoplasmic tail exerts an inhibitory effect upon {alpha}5β1-mediated migration as well as phagocytosis. Since both {alpha}5β1 migration and phagocytosis are events that require the high affinity state of the integrin, and since the {alpha}vβ3-mediated inhibition of {alpha}5β1 is reversed by KN62 in both cases, these data suggest that a common signaling mechanism is responsible for these crosstalk events.

Based on the data in this report, we propose the hypothesis that CamKII, a ser/thr kinase with multiple intracellular substrates, is an important regulator of {alpha}5β1 function and a target of integrin crosstalk. First, ligation of {alpha}5β1 by specific antibody- or ligand-coated beads enhances the activity of CamKII in both macrophages and K562 cells. Second, activation of CamKII by ligation of {alpha}5β1 is required for both phagocytosis and migration. In contrast CamKII inhibitors do not affect adhesion which can be effected by low affinity {alpha}5β1. Thus, the requirement for CamKII activation appears to be specific for the high affinity functions of {alpha}5β1.

Coligation of {alpha}vβ3, or exposure of the isolated β3 cytoplasmic tail, prevents {alpha}5β1-induced rise in CamKII activity. Since the β3 integrin and the CamKII inhibitor have the same effect on {alpha}5β1 function, the data suggest that suppression of the ability of {alpha}5β1 to activate CamKII may be an important mechanism of integrin crosstalk. A role for CamKII suppression in integrin crosstalk is supported by the reversal of crosstalk inhibition of migration with constitutively active CamKII. Thus, our data support the hypothesis that {alpha}5β1-mediated CamKII activation is required for the high affinity functions of migration and phagocytosis and that {alpha}vβ3-activated crosstalk suppresses these functions through inhibition of CamKII activation. Thus, {alpha}5β1 and {alpha}vβ3 have opposing effects on CamKII activity.

Neither the upstream events regulating CamKII nor its downstream effector are yet known. Tyrosine kinase inhibitors have no effect either on the high-affinity functions of {alpha}5β1 or on suppression by {alpha}vβ3, suggesting the possibility that the entire pathway is independent of the well-known effects of integrin ligation on several tyrosine kinases (2, 3). Indeed, the independence of integrin crosstalk from the phosphorylation of Tyr747 further suggests that the signaling involved in the regulation of CamKII may be completely independent of these pathways. A recent report by Wu et al. (25) demonstrates that ligation of {alpha}5β1 and {alpha}vβ3 have opposite effects on plasma membrane calcium channel activity. Since calcium is an important regulator of CamKII, this voltage gated calcium channel may be important in the differential regulation of CamKII by these two integrins. Based on our preliminary pharmacologic data, one likely effector for CamKII in {alpha}5β1 high affinity function is myosin light chain kinase (MLCK). MLCK inhibitors KT5926 and ML9 both reverse {alpha}vβ3 inhibition of {alpha}5β1-mediated phagocytosis and migration without affecting inhibition of CamKII activation by {alpha}vβ3 ligation (Blystone, S.D., and E.J. Brown, unpublished data). MLCK phosphorylation by CamKII is known to inhibit MLCK activity, leading presumably to decreased myosin-induced cell traction (21). This integrin-mediated modulation of myosin function is consistent with the known role for myosin in phagocytosis and migration.

Analysis of structural requirements in the β3 cytoplasmic tail in {alpha}vβ3-mediated crosstalk reveals that Ser752 of the β3 cytoplasmic tail is required for inhibition of CamKII and for initiation of integrin crosstalk, while crosstalk is independent of either of the β3 cytoplasmic tail tyrosines. The requirement for β3 Ser752 in crosstalk is unexpected. The importance of Ser752 was suggested by a mutation to proline in a patient with Glanzmann's Thrombasthenia which abolished high affinity binding of fibrinogen by platelet {alpha}IIbβ3 (6, 8). However, detailed analysis has shown that mutation of Ser752 to Ala does not affect ligand binding by {alpha}IIbβ3 (8). The failure of the Ser752 to Ala β3 mutation to affect ligand binding is supported by our studies in K562 which demonstrate normal adhesion, normal migration (Fig. 2, B and C), and normal generation of the ligand-induced binding site (LIBS) recognized by the antibody LIBS-1 in response to RGD peptide in this mutant (data not shown). In contrast, integrin crosstalk is entirely abolished by the S752A mutation, as it is by mutation to Pro (the original Glanzmann's mutation), to Glu (to mimic a potential phosphorylation), and to Cys (as a conservative mutation). Thus, it appears that Ser is absolutely required at this position. While this suggests the possibility of Ser phosphorylation in integrin crosstalk, we have been unable to demonstrate such phosphorylation so far. In contrast, Tyr747, which is absolutely required for stimulated adhesion and for {alpha}vβ3-mediated migration (Fig. 1) in K562 cells, is not involved in integrin crosstalk. Thus, these two amino acids, closely spaced in the relatively short cytoplasmic domain of one chain of an integrin, mediate two entirely distinct signaling cascades.

In a recent report, Bouvard et al. (5) showed that increased CamKII levels resulted in a decrease in the affinity of {alpha}5β1 for FN. In this in vitro system, CamKII and the phosphatase calcineurin regulate {alpha}5β1 affinity. Because the β3 suppression of {alpha}5β1 phagocytosis occurs subsequent to {alpha}5β1 binding of ligand (3), it is possible that repeated cycling of {alpha}5β1 affinity is required for phagocytosis and migration. Binding of ligand-coated beads to high affinity {alpha}5β1 would activate CamKII, which would then decrease integrin affinity. This hypothesis predicts that integrin crosstalk from {alpha}vβ3 which blocks CamKII activation would prevent {alpha}5β1 movement to the low affinity state. This is entirely consistent with reports of receptor activation rather than inactivation by integrin crosstalk (14, 24) which measured ligand binding rather than functions that require affinity modulation.

Finally, these data demonstrate that, while increased CamKII activity is required for {alpha}5β1-mediated phagocytosis and migration, {alpha}vβ3 can perform these same functions independent of any increase in CamKII. This is a startling example of the diversity of signaling and function among the integrins. It suggests that there may be fundamental differences within this family of closely related receptors in how they mediate even their most basic functions. While many studies have emphasized common features of integrin {alpha}- and β-chains in association with cytoskeleton, calreticulin, and signaling molecules, the differences between {alpha}vβ3 and {alpha}5β1 in requirements for phagocytosis and migration suggest that there will be profound differences among integrins even as they perform similar functions.


   Acknowledgments
 
The authors wish to thank all contributors of cDNAs and antibodies used in these studies and the members of the Brown laboratory for suggestions and advice on the performance of these studies.

Submitted: 30 April 1998

Revised: 8 March 1999

S.D. Blystone is an investigator of the Arthritis Foundation. This work was supported by grants AI24674 and GM38330 from the National Institutes of Health to E.J. Brown. During these studies, S.D. Blystone was a recipient of NRSA AI08990-02 and a grant from the Lucille P. Markey Foundation.


   References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bilato C, Curto K, Monticone RE, Pauly RR, White AJ & Crow MT. The inhibition of vascular smooth muscle cell migration by peptide and antibody agonists of the {alpha}v3integrin complex is reversed by activated calcium/calmodulin-dependent protein kinase II, J Clin Invest, 1997, 100, 693–704.[Medline]
  2. Blystone SD, Graham IL, Lindberg FP & Brown EJ. Integrin {alpha}V3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor {alpha}v1, J Cell Biol, 1994, 127, 1129–1137.[Abstract/Free Full Text]
  3. Blystone SD, Lindberg FP, LaFlamme SE & Brown EJ. Integrin β3 cytoplasmic tail is necessary and sufficient for regulation of alpha5/beta1 phagocytosis by {alpha}V3and integrin associated protein, J Cell Biol, 1995, 130, 745–754.[Abstract/Free Full Text]
  4. Blystone SD, Williams MP, Slater SE & Brown EJ. Requirement of integrin β3 tyrosine 747 for β3 tyrosine phosphorylation and regulation of {alpha}V3avidity, J Biol Chem, 1997, 272, 28757–28761.[Abstract/Free Full Text]
  5. Bouvard D, Molla A & Block MR. Calcium/calmodulin-dependent protein kinase II controls {alpha}51integrin-mediated inside-out signaling, J Cell Sci, 1998, 111, 657–665.[Abstract]
  6. Chen Y-P, Djaffar I, Pidard D, Steiner B, Cieutat A-M, Caen JP & Rosa J-P. Ser-752-> Pro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin {alpha}IIbβ3 (glycoprotein IIb-IIIa) in a variant of , Glanzmann thrombasthenia Proc Natl Acad Sci USA, 1992, 89, 10169–10173.
  7. Chen Y-P, O'Toole TE, Shipley T, Forsyth J, LaFlamme SE, Yamada KM, Shattil SJ & Ginsberg MH. "Inside-out" signal transduction inhibited by isolated integrin cytoplasmic domains, J Biol Chem, 1994, 269, 18307–18310.[Abstract/Free Full Text]
  8. Chen Y-P, O'Toole TE, Ylänne J, Rosa J-P & Ginsberg MH. A point mutation in the integrin β3 cytoplasmic domain (S752-> P) impairs bidirectional signaling through {alpha}IIbβ3(platelet glycoprotein IIb-IIIa), Blood, 1994, 84, 1857–1865.[Abstract/Free Full Text]
  9. Diaz-Gonzalez F, Forsyth J, Steiner B & Ginsberg MH. Trans-dominant inhibition of integrin function, Mol Biol Cell, 1996, 7, 1939–1951.[Abstract]
  10. Gresham HD, Goodwin JL, Anderson DC & Brown EJ. A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis, J Cell Biol, 1989, 108, 1935–1943.[Abstract/Free Full Text]
  11. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z & Damsky CH. Cooperative signalling by alpha5/beta1 and alpha4/ beta1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin, J Cell Biol, 1995, 129, 867–879.[Abstract/Free Full Text]
  12. Hunt TK, Knighton DR, Thakral KK, Goodson WH & Andrews WS. Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages, Surgery, 1984, 96, 48–54.[Medline]
  13. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion, Cell, 1992, 69, 11–25.[Medline]
  14. Ishibashi Y, Claus S & Relman DA. Bordetella pertussisfilamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/ CD18), J Exp Med, 1994, 180, 1225–1233.[Abstract/Free Full Text]
  15. Pacifici R, Roman J, Kimble R, Civitelli R, Brownfield CM & Bizzarri C. Ligand binding to monocyte {alpha}51 integrin activates the {alpha}21 receptor via the {alpha}5subunit cytoplasmic domain and protein kinase C, J Immunol, 1994, 153, 2222–2233.[Abstract]
  16. Pijuan-Thompson V & Gladson CL. Ligation of integrin {alpha}51 is required for internalization of vitronectin by integrin {alpha}V1, J Biol Chem, 1997, 272, 2736–2743.[Abstract/Free Full Text]
  17. Porter JC & Hogg N. Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters {alpha}41- and {alpha}51-mediated function, J Cell Biol, 1997, 138, 1437–1447.[Abstract/Free Full Text]
  18. Ruoslahti E. Integrins, J Clin Invest, 1991, 87, 1–5.[Medline]
  19. Senior RM, Gresham HD, Griffin GL, Brown EJ & Chung AE. Entactin stimulates neutrophil adhesion and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte response integrin (LRI), J Clin Invest, 1992, 90, 2251–2257.[Medline]
  20. Simon KO, Nutt EM, Abraham DG, Rodan GA & Duong LT. The {alpha}21 integrin regulates {alpha}51-mediated cell migration toward fibronectin, J Biol Chem, 1997, 272, 29380–29389.[Abstract/Free Full Text]
  21. Tansey MG, Word RA, Hidaka H, Singer HA, Schworer CM, Kamm KE & Stull JT. Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent kinase II in smooth muscle cells, J Biol Chem, 1992, 267, 12511–12516.[Abstract/Free Full Text]
  22. Turner CE & Miller JT. Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125FAKbinding region, J Cell Sci, 1994, 107, 1583–1591.[Abstract]
  23. van Kooyk Y, Van de Wiel-van Kemenade E, Weder P, Huijbens RJF & Figdor CG. Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium, J Exp Med, 1993, 177, 185–190.[Abstract/Free Full Text]
  24. Van Strijp JAG, Russell DG, Tuomanen E, Brown EJ & Wright SD. Ligand specificity of purified complement receptor type 3 (CD11b/CD18, Mac-1, {alpha}M β2): indirect effects of an Arg-Gly-Asp sequence, J Immunol, 1993, 151, 3324–3336.[Abstract]
  25. Wu X, Mogford JE, Platts SH, Davis GE, Meininger GA & Davis MJ. Modulation of calcium currents in arteriolar smooth muscle by {alpha}V3 and {alpha}51integrin ligands, J Cell Biol, 1998, 143, 241–252.[Abstract/Free Full Text]
  26. Zhou MJ, Lublin DM, Link DC & Brown EJ. Distinct tyrosine kinase activation and Triton X-100 insolubility upon FcRII or FcRIIIB ligation in human polymorphonuclear leukocytes, J Biol Chem, 1995, 270, 13553–13560.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 217K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blystone, S. D.
Right arrow Articles by Brown, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blystone, S. D.
Right arrow Articles by Brown, E. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents